
香港理工大学博士,中国国家标准品委员会专家,11 年企业管理经验,曾任职全球顶尖第三方检测机构。PhD (Hong Kong Polytechnic University); expert of the China National Reference Material Committee; 11 years of corporate management; formerly with a leading global third-party testing organisation.
佳途科技 —— CNAS + ANAB 双体系 ISO 17034 认可的标准物质生产者,以博士级研发团队与自有实验室,支撑全球客户的检测合规与杂质研究。CATO — a CNAS + ANAB ISO 17034 accredited reference material producer, supporting customers worldwide with a PhD-led R&D team and in-house laboratories.
广州佳途科技股份有限公司(CATO Research Chemicals Inc.,简称 CATO / 佳途科技)成立于 2016 年 11 月,专注于分析标准品的研发、检测、赋值及销售,自主品牌为 CATO®。公司以 让检测数据更精准(Make the Tests More Accurate)为使命,面向制药企业、原料药与特殊化学品制造商、CRO / 生物分析机构、IVD 与生物技术企业、第三方检测机构、药监与药检机构、高校院所等,提供全品类标准品、中间体合成、药物杂质制备分离与结构鉴定等服务。CATO Research Chemicals Inc. (CATO) was founded in 2016 年 11 月 and focuses on the R&D, testing, value assignment and supply of analytical reference standards under its own brand CATO®. Guided by the mission “Make the Tests More Accurate”, the company serves pharmaceutical manufacturers, API and speciality chemical producers, CROs and bioanalytical laboratories, IVD and biotech companies, third-party testing organisations, regulators, universities and research institutes — offering reference standards across all categories, custom synthesis, and preparative isolation and structure elucidation of drug impurities.
佳途科技依托小分子化合物合成与分析能力,以及 CNAS + ANAB 双体系 ISO 17034 认证,累计攻克 980 个化合物研发难题,产品矩阵扩展至 1,060,000+ 种,配套超过 95% 主要 API 品种的药物杂质。全部产品提供含 COA 及 HPLC、MS、NMR 等多维度定值数据的完整质量证书。Drawing on its small-molecule synthesis and analytical capability and its dual CNAS + ANAB ISO 17034 accreditation, CATO has solved 980 challenging compounds and grown its catalogue to 1,060,000+ items, covering impurities for more than 95% of major APIs. Every product ships with a full quality certificate including the COA and multi-dimensional value-assignment data (HPLC, MS, NMR).
公司拥有 4,000 m² 研发实验室与 120+ 通风橱,并在珠海、赣州两个百吨级生产基地,产品已销往美国、法国、俄罗斯、印度、巴西等 13+ 国家和地区。合作伙伴涵盖辉瑞(Pfizer)、默克(Merck)、诺华(Novartis)、罗氏(Roche)、龙沙(Lonza)等跨国药企,以及欧陆检测认证(Eurofins)、SGS 等国际检测机构;科研合作机构包括中国科学院上海有机化学研究所、中山大学、南方科技大学、中国药科大学等。The company operates a 4,000 m² R&D laboratory with 120+ fume hoods, plus two hundred-tonne-scale manufacturing bases in Zhuhai and Ganzhou. Products reach more than 13+ countries and regions including the United States, France, Russia, India and Brazil. Partners include multinational pharmaceutical companies such as Pfizer, Merck, Novartis, Roche and Lonza, and international testing organisations such as Eurofins and SGS; research collaborations include the Shanghai Institute of Organic Chemistry (CAS), Sun Yat-sen University, SUSTech and China Pharmaceutical University.

ISO 17034 是国际标准化组织对标准物质生产者能力的最高级别认证,其严苛程度远超一般的实验室认可(ISO/IEC 17025)。CATO 同时持有中国 CNAS 与美国 ANAB 两套 ISO 17034 认证。ISO 17034 is the highest-level accreditation for reference material producers and is considerably more demanding than general laboratory accreditation (ISO/IEC 17025). CATO holds ISO 17034 accreditation from both China CNAS and ANAB (US).
| 认证机构Body | 证书编号Certificate | 范围Scope |
|---|---|---|
| 中国 CNASChina CNAS | CNAS RM0030 | 标准物质/标准样品生产者认可Reference material producer accreditation |
| 美国 ANABANAB (ANSI) | AR-2832 | ISO 17034 标准物质生产者认可ISO 17034 reference material producer |
| SGSSGS | CN18/30447 | ISO 9001:2015 质量管理体系ISO 9001:2015 quality management system |
证书可在 ANAB / CNAS / SGS 官方查询系统核验。Certificates can be verified in the official ANAB, CNAS and SGS directories.
以下均为佳途科技自有实验室实拍 —— 从合成到结构确证、从痕量杂质定量到制备分离,全链条自有能力,不依赖外部代工。All photographs below are taken inside CATO's own laboratories — synthesis, structure elucidation, trace-level quantification and preparative isolation are all performed in-house.






由博士级分析团队主导,可完成一维/二维核磁、质谱、色谱联合结构全解析,以及未知物质探索与 QNMR 定量赋值。Led by a PhD-level analytical team, covering combined 1D/2D NMR, MS and chromatographic structure elucidation, unknown-substance investigation and qNMR value assignment.
技术负责人梁大成博士曾任龙沙制药(Lonza)原合成项目负责人,主导全球首个上市 BTK 抑制剂的工艺开发优化及商业化生产;核心研发成员分别来自药明康德、上海有机化学研究所、沈阳药科大学等知名药企及专业院校。Technical director Dr Liang Dacheng was formerly synthesis project lead at Lonza, where he led process development and commercial manufacturing for the first marketed BTK inhibitor. Core R&D members come from WuXi AppTec, the Shanghai Institute of Organic Chemistry and Shenyang Pharmaceutical University, among others.

香港理工大学博士,中国国家标准品委员会专家,11 年企业管理经验,曾任职全球顶尖第三方检测机构。PhD (Hong Kong Polytechnic University); expert of the China National Reference Material Committee; 11 years of corporate management; formerly with a leading global third-party testing organisation.

中山大学硕士研究生,中国标准品技术委员会委员,15 年国际第三方检测实验室工作经验。MSc (Sun Yat-sen University); member of the China Reference Material Technical Committee; 15 years in international third-party testing laboratories.

中山大学药物化学博士,师从陈新滋院士,曾就职于瑞士 LONZA。深耕手性化学与点击化学,参与开发业内领先的六价硫氟交换(SuFEx)催化体系,成果发表于 ACIE。PhD in medicinal chemistry (Sun Yat-sen University), supervised by Academician Chen Xinzhi; formerly with Lonza (Switzerland). Works on chiral and click chemistry; co-developed the SuFEx catalytic system published in ACIE.

中医医学硕士(河北中医药大学),原海昌制药公司分析部项目负责人,10 年以上药物研发与 4 年标准物质研制经验。MSc (Hebei University of Chinese Medicine); formerly project lead in the analytical department of a pharmaceutical company; 10+ years in drug development and 4 years in reference material development.

理学硕士(纽卡斯尔大学,药物化学),6 年按 ISO 17034 标准运行分析实验室的经验,主导多项分析方法开发与验证。MSc in medicinal chemistry (Newcastle University); 6 years running an analytical laboratory under ISO 17034; leads multiple method development and validation projects.

硕士(华南师范大学),10 年 CDMO 与仿制药中间体从业经验,覆盖工艺研发、中试与生产。MSc (South China Normal University); 10 years in CDMO and generic-drug intermediates, covering process R&D, pilot scale and production.

华侨大学材料科学与工程学士,20 年制药与生物行业供应链管理经验,曾任职富士康、华大基因、强生。BSc in materials science (Huaqiao University); 20 years of supply chain management in pharma and biotech, formerly with Foxconn, BGI and Johnson & Johnson.

20 年仓储物流管理经验,精通仓库运营、库存管控与 ERP 系统实施。20 years in warehouse and logistics management, with deep experience in warehouse operations, inventory control and ERP implementation.
CATO 全自主开发数字化管理平台,覆盖研发、生产、销售与物流全链路,实现产品全生命周期的数字化追溯。内部构建了超过 10,000,000+ 种化合物的结构数据库,支持基于 RDKit 的结构检索与相似度分析,可快速定位合成路线、评估研发可行性 —— 这是高难度杂质项目快速立项的底层基础设施。CATO’s self-developed digital platform spans R&D, production, sales and logistics for full lifecycle traceability. Internally we maintain a structural database of more than 10,000,000+ compounds with RDKit-based substructure and similarity search, allowing synthetic routes to be located and feasibility assessed quickly — the infrastructure behind fast initiation of difficult impurity projects.

每一批产品都经过严格的质量流程后方可放行。Every lot passes a defined quality workflow before release.
多方法交叉定值,评估批内均匀性与稳定性,减少批间差异对定量结果的影响。Cross-checked by multiple methods, with homogeneity and stability assessed to keep lot-to-lot variation out of your results.
NMR、MS、IR、UV 等图谱数据支撑结构确证,COA 可随批索取。NMR, MS, IR and UV data support structural confirmation; the COA is available per lot.
量值可溯源至国家基准与国际标准,满足 ISO 17034 / ISO 17025 对标准物质的要求。Values traceable to national and international standards, meeting ISO 17034 / ISO 17025 requirements for reference materials.
常备库存支持快速放行;对光敏、易挥发与低温品种提供合规包装与运输。Local stock for fast release, with compliant packaging and shipping for light-sensitive, volatile and low-temperature items.